{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:11:21Z","timestamp":1784671881641,"version":"3.55.0"},"reference-count":52,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006175","type":"journal-article","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T00:02:14Z","timestamp":1161302534000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Progesterone for preventing pre-eclampsia and its complications"],"prefix":"10.1002","volume":"2011","author":[{"given":"Shireen","family":"Meher","sequence":"first","affiliation":[{"name":"The University of Liverpool; Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Duley","sequence":"additional","affiliation":[{"name":"University of Nottingham; Nottingham Clinical Trials Unit; B39, Medical School Queen's Medical Centre Campus Nottingham UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"key":"10.1002\/14651858.CD006175-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1192\/bjp.114.516.1377","article-title":"Ante-natal progesterone and intelligence","volume":"114","author":"Dalton","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006175-BIB0002|cit2","first-page":"463","article-title":"Controlled trials in the prophylactic value of progesterone in the treatment of pre-eclamptic toxaemia","volume":"3","author":"Dalton","year":"1969","journal-title":"Journal of Obstetrics and Gynaecology of the British Commonwealth"},{"issue":"4","key":"10.1002\/14651858.CD006175-BIB0004|cit3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0378-3782(78)90060-9","article-title":"Prenatal progesterone II. Its role in the treatment of pre-eclamptic toxaemia and its effect on the offspring's intelligence: a reappraisal","volume":"2","author":"Lynch","year":"1978","journal-title":"Early Human Development"},{"issue":"4","key":"10.1002\/14651858.CD006175-BIB0003|cit4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-3782(78)90059-2","article-title":"Prenatal progesterone I. Its effect on development and on intellectual and academic achievement","volume":"2","author":"Lynch","year":"1978","journal-title":"Early Human Development"},{"key":"10.1002\/14651858.CD006175-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17-alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD006175-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2006.10.003","article-title":"A randomized controlled trial of 17-hydroxyprogesterone caproate (17-OHPC) for the prevention of preterm birth in twins","volume":"195","author":"Caritis","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006175-BIB0007|cit7","unstructured":"Caritis SN Simhan H Relationship of 17-alpha hydroxyprogesterone caproate (17-OHPC) concentrations and gestational age at delivery in twins 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 139"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD006175-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ajog.2008.09.047","article-title":"The impact of cervical length on risk of preterm birth in twin gestations","volume":"199","author":"Durnwald","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD006175-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.ajog.2008.09.720","article-title":"17-alpha hydroxyprogesterone caproate does not increase the risk of gestational diabetes in singleton and twin pregnancies","volume":"199","author":"Horton","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD006175-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006175-BIB0011|cit11","unstructured":"Simhan HN Caritis SN The effect of 17-alpha hydroxyprogesterone caproate (17-OHPC) on maternal plasma CRP levels in twin pregnancies 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 140"},{"key":"10.1002\/14651858.CD006175-BIB0012|cit12","unstructured":"US National Institutes of Health Trial of progesterone in twins and triplets to prevent preterm birth (STTARS) http:\/\/www.clinicaltrials.gov\/ct\/gui\/show\/NCT00099164"},{"key":"10.1002\/14651858.CD006175-BIB0014|cit13","unstructured":"Norman JE Double blind randomised placebo controlled study of progesterone for the prevention of preterm birth in twins (STOPPIT) (ongoing trial) National Research Register (www.nrr.nhs.uk)"},{"issue":"9680","key":"10.1002\/14651858.CD006175-BIB0013|cit14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006175-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1192\/bjp.129.5.438","article-title":"Prenatal progesterone and educational attainments","volume":"129","author":"Dalton","year":"1976","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006175-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"key":"10.1002\/14651858.CD006175-BIB0017|cit17","first-page":"692","article-title":"Inefficacy of 17 alpha-hydroxyprogesterone caproate in prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD006175-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00016347509157760","article-title":"Progesterone therapy in pre-eclamptic toxaemia","volume":"54","author":"Sammour","year":"1975","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD006175-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/10641958209009619","article-title":"Progesterone therapy in pregnancy induced hypertension therapeutic value and hormonal profile","volume":"1","author":"Sammour","year":"1982","journal-title":"Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD006175-BIB0020|cit20","unstructured":"Nassar AH Prevention of preterm delivery in twin pregnancies by 17 alpha hydroxyprogesterone caproate ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/) (accessed 10 February 2009)"},{"key":"10.1002\/14651858.CD006175-BIB0021|cit21","unstructured":"Uckele JE Oral progesterone and low dose aspirin in the prevention of preeclampsia metaRegister of Controlled Trials (http:\/\/www.controlled-trials.com\/mrct\/trial\/454661\/preeclampsia)"},{"key":"10.1002\/14651858.CD006175-BIB0022|cit22","first-page":"11","article-title":"Progesterone in pre-eclamptic toxaemia","volume":"38","author":"Bennett","year":"1939","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD006175-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/oxfordjournals.humrep.a135775","article-title":"Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones","volume":"10","author":"Buhimschi","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006175-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.4896.1071","article-title":"Similarity of symptomatology of premenstrual syndrome and toxaemia of pregnancy and their response to progesterone","volume":"2","author":"Dalton","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006175-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/bmj.2.5041.378","article-title":"Toxaemia of pregnancy treated with progesterone during the symptomatic stage","volume":"2","author":"Dalton","year":"1957","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006175-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(60)90113-6","article-title":"Early symptoms of pre-eclamptic toxaemia","volume":"1","author":"Dalton","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006175-BIB0027|cit27","volume-title":"Why mothers die. The sixth report on confidential enquiries into maternal deaths in the United Kingdom 2000-2002","author":"Public","year":"2002"},{"issue":"1","key":"10.1002\/14651858.CD006175-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004947.pub2","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD006175-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006175-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003415.pub3","article-title":"Progesterone for premenstrual syndrome","author":"Ford","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006175-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005301","article-title":"Interventions for preventing pre-eclampsia and its consequences: generic protocol","author":"Meher","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006175-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003511.pub2","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"20","key":"10.1002\/14651858.CD006175-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006175-BIB0034|cit34","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"4","key":"10.1002\/14651858.CD006175-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9378(11)90617-6","article-title":"The blood pressure response to infusions of angiotensin II during normal pregnancy: relation to plasma angiotensin II concentration, serum progesterone level, and mean platelet volume","volume":"166","author":"Ito","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006175-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1002\/14651858.CD006175-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/oxfordjournals.humrep.a019209","article-title":"Regulation of vascular adaptation during pregnancy and post-partum: effects of nitric oxide inhibition and steroid hormones","volume":"11","author":"Liao","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006175-BIB0038|cit38","first-page":"1221","article-title":"Treatment with progesterone of eight cases of pre-eclampsia","volume":"2","author":"Marsden","year":"1937","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006175-BIB0039|cit39","first-page":"1","article-title":"Report of the national high blood pressure education program working group on high blood pressure in pregnancy","volume":"183 Suppl","author":"Gifford","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD006175-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0002-9378(79)90391-0","article-title":"Hormone production during pregnancy in the primigravid patient. I. Plasma levels of progesterone and 5-alpha-pregnane-3,20-dione throughout pregnancy of normal women and women who developed pregnancy-induced hypertension","volume":"135","author":"Parker","year":"1979","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006175-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0039-128X(93)90102-S","article-title":"The role of reproductive hormones in vascular disease and hypertension","volume":"58","author":"Radwanska","year":"1993","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD006175-BIB0042|cit42","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2003"},{"key":"10.1002\/14651858.CD006175-BIB0043|cit43","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD006175-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/bmj.1.3971.311","article-title":"Progesterone in pre-eclamptic toxaemia","volume":"1","author":"Robson","year":"1937","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006175-BIB0045|cit45","volume-title":"Immunosuppression by progesterone in pregnancy","author":"Szekeres-Bartho","year":"1992"},{"issue":"7","key":"10.1002\/14651858.CD006175-BIB0046|cit46","first-page":"647","article-title":"Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring","volume":"12","author":"Tamimi","year":"2003","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"issue":"3","key":"10.1002\/14651858.CD006175-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005943.pub2","article-title":"Progestogen for treating threatened miscarriage","author":"Wahabi","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006175-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9378(88)90782-X","article-title":"Geographic variation in the incidence of hypertension in pregnancy","volume":"158","author":"World Health Organization International Collaborative Study of Hypertensive Disorders in Pregnancy","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD006175-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2004.01.033","article-title":"HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia","volume":"191","author":"Yie","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD006175-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humrep\/dei305","article-title":"Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro","volume":"21","author":"Yie","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD006175-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bmj.1.3983.953","article-title":"The habitual abortion and stillbirth syndrome and late pregnancy toxaemia: vitamin E and the prolan-progesterone mechanism","volume":"1","author":"Young","year":"1937","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD006175-BIB0052|cit52","first-page":"362","article-title":"Serum levels of progesterone in patients with preeclampsia","volume":"112","author":"Zeisler","year":"2000","journal-title":"Wiener Klinische Wochenschrift"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006175\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T09:03:18Z","timestamp":1646989398000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006175"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006175","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,18]]}}}